Fractyl Health
GUTS • NASDAQ
Fractyl Health is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Harith Rajagopalan, with a market cap of $71.2M.
CEOHarith Rajagopalan
Next Earnings
Upcoming earnings announcement for Fractyl Health
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.16
Earnings History
Past 9 earnings reports for Fractyl Health
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 24, 2026 | Q4 2025 | -$0.07Est: -$0.18 | +61.1% | - | — |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.71Est: -$0.33 | -115.2% | - | — | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.57Est: -$0.36 | -58.3% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.49 | — | — | — | 10-Q |
| Mar 3, 2025 | Q4 2024 | -$0.52Est: -$0.44 | -18.2% | $3.0KEst: $10.0K | -70.0% | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.48Est: -$0.50 | +4.0% | $14.0K | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.36Est: -$0.46 | +21.7% | $43.0K | — | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.17Est: -$0.30 | +43.3% | $33.0K | — | 10-Q |
| Apr 1, 2024 | Q4 2023 | -$8.02 | — | $7.0K | — | — |